| P2093 | author name string | Guang-Xiu Lu | |
| | Dan Zhu | |
| | Ju Peng | |
| | Jun-Jian Hu | |
| | Lian-Sheng Chen | |
| | Pei He | |
| P2860 | cites work | Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene | Q27860693 |
| | Untangling the ErbB signalling network | Q27860884 |
| | Growth factor signaling by receptor tyrosine kinases | Q29618315 |
| | Specific down-regulation of HER-2/neu mediated by a chimeric U6 hammerhead ribozyme results in growth inhibition of human ovarian carcinoma. | Q32124964 |
| | Use of a U16 snoRNA-containing ribozyme library to identify ribozyme targets in HIV-1 | Q33326968 |
| | Ribozymes. Their design and use in cancer | Q33918315 |
| | A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus | Q33944754 |
| | Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assay | Q33970193 |
| | HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer. | Q34346068 |
| | The role of c-erbB-2/HER2/neu in breast cancer progression and metastasis | Q34639829 |
| | Small catalytic RNAs | Q35671068 |
| | Oncolytic viral therapies - the clinical experience | Q36318202 |
| | Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas | Q36367428 |
| | RNAi in combination with a ribozyme and TAR decoy for treatment of HIV infection in hematopoietic cell gene therapy | Q36673668 |
| | Reduction in severity of a herpes simplex virus type 1 murine infection by treatment with a ribozyme targeting the UL20 gene RNA. | Q36804560 |
| | Sequence specificity of the hammerhead ribozyme revisited; the NHH rule | Q39724988 |
| | Differences in radiosensitivity between three HER2 overexpressing cell lines | Q40025423 |
| | Downregulation of wild-type p53 protein by HER-2/neu mediated PI3K pathway activation in human breast cancer cells: its effect on cell proliferation and implication for therapy. | Q40476195 |
| | Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation | Q40550797 |
| | Reversion of the malignant phenotype of gastric cancer cell SGC7901 by c-erbB-2-specific hammerhead ribozyme. | Q40759616 |
| | HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation | Q40767550 |
| | c-erbB-2/neu oncogene and Ki-67 analysis in the assessment of palatal salivary gland neoplasms | Q40992517 |
| | Expression of the erbB-2 family of growth factor receptors and their ligands in breast cancers. Implication for tumor biology and clinical behavior. | Q41016613 |
| | HER-2/neu signal transduction in human breast and ovarian cancer | Q41328221 |
| | erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells | Q42807469 |
| | Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. | Q42811529 |
| | Recombinant adenovirus encoding H-ras ribozyme induces apoptosis in laryngeal cancer cells through caspase- and mitochondria-dependent pathways | Q45856178 |
| | Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells | Q45865606 |
| | Adenovirus-mediated anti-K-ras ribozyme induces apoptosis and growth suppression of human pancreatic carcinoma | Q45866772 |
| | Intracellular antibody against erbB-2 mediates targeted tumor cell eradication by apoptosis | Q45877626 |
| | Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues | Q46076087 |
| | Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities | Q73148838 |
| P433 | issue | 3 | |
| P921 | main subject | ribozyme | Q205858 |
| P304 | page(s) | 1597-1604 | |
| P577 | publication date | 2009-05-15 | |
| P1433 | published in | Molecular Biology Reports | Q15752755 |
| P1476 | title | pcDNA3.1(-)-mediated ribozyme targeting of HER-2 suppresses breast cancer tumor growth | |
| P478 | volume | 37 | |